Anne Lautenbach (A Lautenbach)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Bariatric Surgery

Top Venues

Obesity surgery

Diabetes/metabolism research and reviews

Diabetes, obesity & metabolism

International journal of obesity (2005)

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Forst, Christophe E M De Block, Stephano Del Prato, Sara Armani, Juan Pablo Frias, Anne Lautenbach, Bernhard Ludvik, Marina Marinez, Chantal Mathieu, Timo Dirk Müller, Oliver Schnell
The role of incretin receptor agonists in the treatment of obesity. Diabetes, obesity & metabolism (2024)
Anne Lautenbach, Tobias Kantowski, Jonas Wagner, Oliver Mann, Fabian Stoll, Jens Aberle
Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure. Clinical obesity (2023)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery 33 (2) (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Philipp Busch, Tobias B Huber, Fabian Stoll, Jens Aberle
Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery. International journal of obesity (2005) 46 (4) (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery 33 (2) (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery 33 (2) (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery 33 (2) (2022)
Anne Lautenbach, Marie Wernecke, Oliver Mann, Jonas Wagner, Stefan Wolter, Fabian Stoll, Jens Aberle
Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery. Obesity surgery 33 (2) (2022)
Anne Lautenbach, Marie Wernecke, Tobias B Huber, Fabian Stoll, Jonas Wagner, Sebastian M Meyhöfer, Svenja Meyhöfer, Jens Aberle
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis. Obesity surgery 32 (10) (2022)
Anne Lautenbach, Fabian Stoll, Oliver Mann, Philipp Busch, Tobias B Huber, Heike Kielstein, Ina Bähr, Jens Aberle
Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery. Obesity surgery 31 (7) (2021)
Anne Lautenbach, Jan-Wilhelm Wienecke, Fabian Stoll, Nina Riedel, Oliver Mann, Tobias B Huber, Philipp Busch, Jens Aberle
Bariatric Surgery Is Protective Against Renal Function Decline in Severely Obese Patients in the Long-Term. Obesity surgery 31 (3) (2020)
Anne Lautenbach, M Wernecke, N Riedel, J Veigel, J Yamamura, S Keller, R Jung, P Busch, O Mann, F K Knop, J J Holst, J J Meier, J Aberle
Adaptive changes in pancreas post Roux-en-Y gastric bypass induced weight loss. Diabetes/metabolism research and reviews 34 (7) (2018)